Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study
Hongwei Zuo,
Weisi Dai,
Jie Mao,
Mei Ye,
Xingshan Lu,
Xiaocui Zhang
Wiley ·
2026-11-05
· DOI 10.1002/1744-9987.70178
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Hongwei Zuo, Weisi Dai, Jie Mao, Mei Ye, Xingshan Lu, Xiaocui Zhang. Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study. // Therapeutic Apheresis and Dialysis. – 2026. – DOI: 10.1002/1744-9987.70178. – URL: https://onlinelibrary.wiley.com/doi/10.1002/1744-9987.70178?af=R
Hongwei Zuo, Weisi Dai, Jie Mao, Mei Ye, Xingshan Lu, & Xiaocui Zhang (2026). Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study. Therapeutic Apheresis and Dialysis. https://doi.org/10.1002/1744-9987.70178
Hongwei Zuo, et al. “Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study.” Therapeutic Apheresis and Dialysis, 2026. doi:10.1002/1744-9987.70178.
@article{Zuo2026,
title = {Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study},
author = {Zuo, Hongwei and Dai, Weisi and Mao, Jie and Ye, Mei and Lu, Xingshan and Zhang, Xiaocui},
journal = {Therapeutic Apheresis and Dialysis},
year = {2026},
doi = {10.1002/1744-9987.70178},
url = {https://onlinelibrary.wiley.com/doi/10.1002/1744-9987.70178?af=R}
}